With Treatment
Tadiso Inc is treatment center located at 1425 Beaver Avenue in the 15233 zip code in Pittsburgh, PA that offers medication assisted substance abuse treatment. It accepts people with trauma, pregnant/postpartum women and adult women into its treatment program. Tadiso Inc provides methadone maintenance and buprenorphine maintenance to adults and young adults. Some of the treatment approaches used by Tadiso Inc consist of relapse prevention, matrix Model and rational emotive behavioral therapy.
Address: 1425 Beaver Avenue, Pittsburgh, PA 15233
Here are the full facility listing details on Tadiso Inc in Pittsburgh, PA:
Types of Care at Tadiso Inc
Service Settings at Tadiso Inc
Opioid Medications used in Treatment at Tadiso Inc
Type of Alcohol Use Disorder Treatment at Tadiso Inc
External Source of Medications Used for Alcohol Use Disorder Treatment at Tadiso Inc
Type Of Treatment at Tadiso Inc
Pharmacotherapies at Tadiso Inc
Treatment Approaches at Tadiso Inc
FacilityOwnership at Tadiso Inc
License/Certification/Accreditation at Tadiso Inc
Payment/Insurance/Funding Accepted at Tadiso Inc
Special Programs/ Population Groups Supported at Tadiso Inc
Assessment/Pre-treatment at Tadiso Inc
Screening & Testing at Tadiso Inc
Transitional Services at Tadiso Inc
Ancillary Services at Tadiso Inc
Other Addictions Treatment at Tadiso Inc
Counseling Services and Education at Tadiso Inc
Tobacco/Screening Services at Tadiso Inc
Facility Smoking Policy at Tadiso Inc
Age Groups Accepted at Tadiso Inc
Gender Accepted at Tadiso Inc
Phone #: 412-322-8415 x125
Call (866) 434-2077 for 24/7 help with treatment.
Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at Tadiso Inc. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.
Here are some key points to consider regarding the safety of methadone treatment:
Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.
Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.
Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).
Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.
Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.
However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.
Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like Tadiso Inc to conduct a thorough assessment before starting someone on methadone.
Other drug and rehab centers within 75 miles of Tadiso Inc: